TABLE 2.

Study data overview

Drugs	Unsolicited reports			Solicited reports
	ID reports	Listed reports	Unlisted reports	ID reports	Listed reports	Unlisted reports
Carbamazepine	5334	58 734	85 291	386	1704	9031
Fluvastatin IRb	45	13 501	13 820	3	658	4626
Basiliximab	1316	2866	5207	665	2169	4988
Fluvastatin ERc	27	5309	5897	5	404	1607
Zoledronic acid‐Z d	8305	66 800	109 979	1162	10 166	18 641
Imatinib	21 383	134 806	37 901	16 396	71 083	23 759
Zoledronic acid‐A d	1688	90 810	49 985	1697	25 921	32 736
Deferasirox	2932	30 877	35 352	2920	18 014	32 850
Vildagliptin	2468	13 991	10 673	7502	17 831	20 658
Sacubitril/valsartan	4252	12 982	10 747	10 175	14 344	27 473

^asales data available from 01 January 1998; ^b IR: immediate release; ^c ER: extended release.

^dFormulations representing 2 separate marketed products.